Program Detail

Program Detail

Modality
Program #
Program
indication
Presentation
mRNA-1172 \nmRNA-1777

Source
Respiratory syncytial virus (RSV) vaccine

mRNA-1172 \nmRNA-1777
Last program update Jan 13, 2020
mRNA-1647

Source
Cytomegalovirus (CMV) vaccine

mRNA-1647
Last program update Jan 13, 2020
mRNA-1653

Source
Human metapneumovirus and parainfluenza virus 3 (hMPV/PIV3) vaccine

mRNA-1653
Last program update Jan 13, 2020
mRNA-1851

Source
Influenza H7N9 vaccine

mRNA-1851
Last program update Jan 13, 2020
mRNA-1893

Source
Zika vaccine

mRNA-1893
Last program update Jan 13, 2020
mRNA-4157

Source
Personalized Cancer Vaccine (PCV) \n\iSolid tumors/i

mRNA-4157
Last program update Jan 13, 2020
mRNA-5671

Source
KRAS vaccine \n\iCRC, NSCLC, pancreatic cancer/i

mRNA-5671
Last program update Jan 13, 2020
mRNA-2416

Source
OX40L \n\iSolid tumors/lymphoma/i\n\iAdvanced ovarian carcinoma/i

mRNA-2416
Last program update Jan 13, 2020
mRNA-2752

Source
OX40L/IL-23/IL-36y \n\iSolid tumors/lymphoma/i

mRNA-2752
Last program update Jan 13, 2020
MEDI1191

Source
IL-12 \n\iSolid tumors/i

MEDI1191
Last program update Jan 13, 2020
AZD8601

Source
VEGF-A \n\iMyocardial ischemia/i

AZD8601
Last program update Jan 13, 2020
mRNA-1944

Source
Antibody against Chikungunya virus

mRNA-1944
Last program update Jan 13, 2020
AZD7970

Source
Relaxin \n\iHeart failure/i

AZD7970
Last program update Jan 13, 2020
mRNA-3630

Source
α-GAL \n\iFabry disease/i

mRNA-3630
Last program update Jan 13, 2020
mRNA-6981

Source
PD-L1

mRNA-6981
Last program update Jan 13, 2020
mRNA-6231

Source
IL-2

mRNA-6231
Last program update Jan 13, 2020
mRNA-3704

Source
MUT \n\iMethylmalonic acidemia (MMA)/i

mRNA-3704
Last program update Jan 13, 2020
mRNA-3927

Source
PCCA/PCCB\n\iPropionic acidemia (PA)/i

mRNA-3927
Last program update Nov 06, 2019
mRNA-3283

Source
PAH \n\iPhenylketonuria (PKU)/i

mRNA-3283
Last program update Jan 13, 2020
mRNA-3745

Source
G6Pase \n\iGlycogen storage disorder type 1a (GSD1a)/i

mRNA-3745
Last program update Jan 13, 2020